Clinical trials

167

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Recruiting

SAGE-Heart : Senior Assessment fraGility and Post-opErative QALYs 1 Year After Emergency HEART Surgery for Patients Aged 75 and Older

The hypothesis is that the preoperative Clinical Frailty Score (CFS) is a predictive factor for a loss in quality-adjusted life years (QALYs) one year after emergency cardiac surgery under cardiopulmonary bypass (CPB) in patients aged 75 years and older.

Participants needed: 265
Trial details
Age: 75+Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Jun 30, 2026Locations: 1
Eligibility criteria

Immediate emergency surgery: intervention performed before the start of the next... [+1]

Patients requiring preoperative cardiopulmonary resuscitation [+5]

Status: Not yet recruiting

Model Early Immunologic Stages of Pediatric Hematological Pre-lupus

Immunologic thrombocytopenic purpura (ITP) in children is a pre-lupus condition if associated with the presence of anti-nuclear antibodies (ANA), providing a unique model for understanding the natural history of autoimmunity, particularly that of systemic lupus erythematosus (SLE). We will describe the shared and/or unique immunological pathways involved at diagnosis in 70 children with ITP and in 20 children with SLE, and compare them between ITP-ANA- (more often transient), ITP-ANA+ (pre-lupus condition, more often persistent) and SLE

Participants needed: 105
Trial details
Age: 1-18Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Jul 1, 2026Locations: 2
Eligibility criteria

Child or adolescent with newly diagnosed ITP or SLE according to the specific de... [+8]

ITP secondary to a known cause: previous or concomitant immune deficiency, bone... [+6]

Status: Recruiting

UroCCR Database: French Research Network for Kidney Cancer -UroCCR

Kidney cancer management has become increasingly complex with the diversification of treatment options and the integration of multidisciplinary care. To meet these challenges, the UroCCR network was established in France as a national registry and research platform dedicated to renal cancer. Funded by the French National Cancer Institute (INCa), UroCCR prospectively collects comprehensive real-world data on patient care and disease evolution, while systematically linking these records with annotated biological samples (plasma, urine, and both healthy and tumour tissues). For each case, more than one thousand variables may be recorded, covering clinical, imaging, and patient-reported information. More than a registry, UroCCR is a collaborative network of clinical and research professionals using a shared, evolving tool that supports rapid implementation of studies and fosters active knowledge generation. Unlike retrospective registries or sample-centred biobanks, UroCCR offers prospective, patient-focused inclusion and a wide scope of investigation-from translational and technological research to clinical evaluation and social sciences. It also supports multiple ancillary studies, including retrospective analyses and prospective clinical or observational trials, and operates under a structured governance system with recognised national and international labels. By combining a rigorously structured, multicentre dataset with linkage to the French national health data system (SNDS), the platform uniquely unites detailed clinical annotation with population-wide coverage, creating a high-value environment for advancing kidney cancer research and care.

Participants needed: 30,000
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, BordeauxUpdated: Jun 25, 2026Locations: 68
Eligibility criteria

Adult patient with kidney cancer [+1]

Status: Not yet recruiting

Morphology in Oral Rare Syndromes & Artificial Intelligence for Clinical Diagnosis

MOSAIC aims to determine whether oro-dental morphological anomalies, particularly palatal morphology, associated with rare bone and cartilage diseases can be precisely characterized using 3D digital models analysed through geometric morphometrics. The study will also evaluate whether these morphological signatures can train an artificial intelligence (AI) algorithm to classify syndromes. A prospective monocentric case-control cohort will be constituted, including 3D intra-oral scans and associated clinical data. The final goal is to improve diagnostic accuracy and reduce diagnostic delay in rare bone disorders.

Participants needed: 240
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Jun 24, 2026Locations: 1
Eligibility criteria

For cases: Diagnosis of a rare bone and cartilage disorder confirmed by the Rare... [+3]

History of major orthodontic/orthognathic treatment; [+3]

Status: Not yet recruiting

Advancing Neurogenetic Diagnoses Through Long-Read Sequencing

Nucleotide repeats emerge as one of the most prolific classes of genetic variations. They have the propensity to in-crease in length across generations, and have been implicated in at least 65 known neurological/ neurodevelop-mental and neuromuscular conditions. Simultaneous analysis of all these nucleotide repeats is now possible through the cutting-edge methodologies recently developed that are the long-read sequencing and the optical genome mapping. Investigator propose to test these methodologies in patients carrying expansions in those repeats and to determine the capacity of these technics to detect novel repeats in patients with no genetic diagnosis yet.

Participants needed: 304
Trial details
Age: 6-60Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Jun 24, 2026Locations: 2
Eligibility criteria

Participants affiliated with or beneficiaries of a social security scheme [+18]

By the parents or the holder of parental authority for patients under the age of... [+3]

Status: Not yet recruiting

JUgular Gating for Upright Level Adjustment and Targeted Enhancement of Cerebral Perfusion

Investigators aim to demonstrate that the evolution of intracranial pressure (ICP) is nonlinear and may be influenced by jugular vein collapse. This collapse is estimated to occur at the angle where the hydrostatic pressure of the blood column matches the central venous pressure, and it can be assessed using ultrasonography. This approach allows for the determination of an individualized tilt angle, optimizing cerebral perfusion pressure without compromising venous drainage.

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, BordeauxUpdated: Jun 24, 2026Locations: 1
Eligibility criteria

Patients ≥ 18 years old [+8]

Contraindication to trunk mobilization. [+5]

Status: Recruiting

Intestine-lung Axis of Cystic Fibrosis Patients Treated With the Combination Elexacaftor/Tezacaftor/Ivacaftor

Cystic fibrosis is a systemic disease, which affects in particular the respiratory and digestive systems of patients, sites of chronic inflammation. A new combination of elexacaftor/tezacaftor/ivacaftor has proven its efficacy for the treatment of patients aged 12 years and over with two F508del mutations or a so-called "minimal function" mutation associated with one F508del mutation. European marketing authorization was obtained in August 2020 and access in France should therefore arrive soon. Given that this treatment targets new mutations and that the efficacy seems greater than with LUM/IVA, it is important to assess its impact on the microbiota and the pulmonary and digestive inflammation of patients. It is therefore a question of taking advantage of the experience of the Lum-Iva-Biota cohort, and the validated and operational sample circuit established in the various participating centers to set up a biological collection for the collection and storage of sputum and stools of patients during the first year of treatment with elexacaftor/tezacaftor/ivacaftor, in order to study the effect of treatment on the lung and digestive microbiota/mycobiota and inflammation.

Participants needed: 253
Trial details
Age: 6-17Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Jun 22, 2026Locations: 15
Eligibility criteria

To have cystic fibrosis (sweat test > 60 mmol/l); [+7]

Start of treatment with elexacaftor/tezacaftor/ivacaftor as part of a therapeuti... [+2]

Status: Recruiting

COmbined pLaTelet and eRythrocyte AutotransfusioN During Cardiac surgEry (COLTRANE) Trial

Despite significant advances in patient blood management, cardiac surgery remains a surgical procedure at high risk for bleeding. Numerous perioperative blood conservation strategies have been developed for limiting the use of blood products. Among them, the processing of shed blood and residual cardiopulmonary bypass circuit volume with autotransfusion device is routinely used. Conventional centrifugation-based autotransfusion devices actually available only recover red blood cells while platelets and coagulation factors are almost totally lost. Consequently, large amounts of intraoperative cell salvage could significantly alter perioperative haemostasis. The SAME autotransfusion device (i-SEP, France) is a new and innovative filtration-based autotransfusion device able to recover erythrocytes, leukocytes but also platelets. By offering the opportunity to re-infuse to patients their own platelets in addition red blood cells, significantly improve perioperative haemostasis with this new device is expected. The purpose of the COLTRANE trial is to compare the quality of the perioperative haemostasis in cardiac surgical patients for whom intraoperative cell salvage will be performed using either the SAME autotransfusion device or conventional centrifugation-based device. Because allogenic transfusion of blood products as well as surgical re-exploration for excessive bleeding are associated with poor outcomes and prolonged length of stay, the use of filtration-based SAME device by maintaining perioperative haemostasis could improve outcomes and reduce length of stay of high risk patients. The fact that patients receive their own platelets should also limit the risk of allo-immunization and immunomodulation which is recognized as one of the underlying mechanisms of perioperative increased risk of infection.

Participants needed: 570
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Jun 11, 2026Locations: 10
Eligibility criteria

Primary or redo combined cardiac procedures (2 valves or more, valve(s) and coro... [+3]

Preoperative therapy by P2Y12 receptor inhibitors (within 5 preoperative days fo... [+18]

Status: Recruiting

In Vivo Involvement of the Cholinergic and Dopaminergic Systems in the Pathophysiology of Apathy.

Apathy is a neurocognitive syndrome characterized by reduced goal-directed behaviors, contributing to decreased patient and caregiver quality of life. Apathy pathophysiology involves disruption of cortico-striato-thalamo-cortical loops, modulated by several neurotransmitter systems including dopamine and acetylcholine, thus complexifying pharmacological management. Post-stroke apathy (PSA) can provide a proper in vivo model to study the underlying neurochemical substrates of apathy as a syndrome. The present project aims to provide a better characterization of the cholinergic and dopaminergic functioning in apathy as a syndrome. In order to precise the respective alterations of these two systems, investigators will use a positron emission tomography (PET) molecular imaging of dopaminergic (with \[18F\]-FDOPA, a marker of the decarboxylating enzyme of dopamine) and - for the first time in apathetic patients - cholinergic (with \[18F\]-FEOBV, a marker of the vesicular acetylcholine transporter) transmissions in 15 apathetic and 15 unapathetic patients 3 months after stroke, without overlapping depression. This dual imaging study may provide help in guiding therapeutic management of PSA. The functional network analysis allowed by functional MRI is crucial to complement regional neurotransmitter deficits observed with PET. Altogether, a multimodal approach in apathy, combining PET and MRI, can allow identifying which circuits of the cortico-striato-thalamo-cortical loops are disrupted and how these circuits are modulated by other neurotransmitters.

Participants needed: 30
Trial details
Phase: Phase 3Age: 18-75Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Jun 10, 2026Locations: 1
Eligibility criteria

Patient of legal age and younger than 75 years [+4]

Patients over 75 years old [+17]

Status: Recruiting

AntiPlatelet theraPy stratEgy followiNg Left Atrial appenDAGe closurE

The APPENDAGE study is a phase 4 multicentre randomized opened clinical trial comparing 2 different antithrombotic strategies following left atrial appendage closure (LAAC) in patients with non valvular atrial fibrillation (AF). The primary objective of the study is to evaluate the efficacy of Aspirin versus Aspirin + Clopidogrel after LAAC by comparing the occurrence of ischemic lesions on cerebrovascular magnetic resonance imaging (MRI) studies.

Participants needed: 60
Trial details
Phase: Phase 4Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Jun 10, 2026Locations: 2
Eligibility criteria

Male or female patients with LAAC indication according to "Commission nationale... [+4]

Minors [+20]

Status: Recruiting

Early Oxybutinin Treatment for Boys With Posterior Urethral Valves

Boys with posterior urethral valves have bladder dysfunction of varying severity. Early treatment of these children with anticholinergics is recommended by some teams, although there have never been any clear studies on the subject. To our knowledge, no comparative study of the evolution of valve bladders with or without treatment has been carried out to date. Anticholinergic treatment, although it may be beneficial in patients with abnormal bladder function, such as the neurologic bladders ( in Spina Bifida) for example, may have side effects and may not be of benefit for this valve population. The evolution of the valves could be spontaneously favorable. This study would be the first randomized clinical trial of early therapeutic drug intervention in the posterior urethral valve population.

Participants needed: 50
Trial details
Phase: Phase 2Age: 3-6Biological sex: MaleType: InterventionalSponsor: University Hospital, BordeauxUpdated: Jun 10, 2026Locations: 1
Eligibility criteria

Boys [+6]

Boys with posterior urethral valves and normal urodynamics or no urodynamic asse... [+3]

Status: Recruiting

Management of Bone Loss in Orthopaedic Surgery Using the Masquelet Technique or Transport Nails

This is a single-center prospective observational study comparing two techniques for reconstructing bone loss in the lower limbs. The aim of the study was to compare the results of reconstructions using the Masquelet technique with reconstructions using electromagnetic transport nails. The primary endpoint was time to bone healing. This study is the first prospective descriptive study of electromagnetic transport nails.

Participants needed: 250
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Jun 5, 2026Locations: 1
Eligibility criteria

Patient ≥ 18 years [+5]

Patients under guardianship or curatorship, [+7]

Status: Recruiting

Dispensing of Antibiotics in Pharmacies for Cystitis According to a Delegation Protocol, Impact of a Decision Support Tool. PHARIBO: PHarmacy and Resolved Antibiotherapy for Urinary Tract Infections

The purpose of this trial is to demonstrate that when treating acute cystitis without risk of complication, pharmacists may use share Decision Making tool to help patients to better understand the stakes of taking antibiotics and adapt the management of the delegation protocol. This will select patients in need of antibiotics and preserve the full-capacities of non-treated one.

Participants needed: 506
Trial details
Age: 18-65Biological sex: FemaleType: InterventionalSponsor: University Hospital, BordeauxUpdated: Jun 8, 2026Locations: 14
Eligibility criteria

woman, [+3]

anomaly of the urinary canal, [+9]

Status: Recruiting

Identification of the Metabolic Signature of Atrial Fibrillation for Personalized Prevention

Atrial fibrillation (AF) is a major public health problem. The efficacy of the existing techniques is limited in the more aggressive forms. It is therefore necessary to develop approaches, in particular the identification of relevant biomarkers, to prevent the onset, recurrence or progression of AF in at-risk patients. The objective of this study is to describe the longitudinal metabolic and biomolecular signature of AF in patients eligible for cardiac ablation.

Participants needed: 400
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Jun 9, 2026Locations: 1
Eligibility criteria

Age ≥ 18 years, all genders, and ethnic origins [+2]

Age < 18 years [+8]

Status: Recruiting

Evaluation of the Evolution of Patient Care Within the Spinal Pathology Department

Spinal conditions are a major public health issue. Their management by surgical treatment is constantly improving and surgical procedures or implantable medical devices are experiencing significant progress. These innovations have not yet all been precisely evaluated but have already led to significant changes in care practices. The primary objective of our study is to describe, via an exhaustive collection of data, the quarterly evolution over 5 years of practices in the management of spinal pathologies.

Participants needed: 15,000
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Jun 4, 2026Locations: 1
Eligibility criteria

Patient > 18 years old [+2]

Patient under guardianship or curators, [+5]

Status: Recruiting

Contribution of Anti-platelet Antibodies Identified With MAIPA Assay in the Demonstration of the Auto-immune Character of a Thrombocytopenia at Diagnosis

Immune thrombocytopenia (ITP) is an autoimmune disease but, paradoxically, and unlike other autoimmune diseases, antiplatelet antibodies are not used either for the diagnosis of the disease or for its prognosis. ITP is a diagnosis of exclusion retained after elimination of other pathologies leading to a thrombocytopenia. No major study has prospectively evaluated the diagnostic value of the presence of anti-platelet antibodies in the etiological investigation of a thrombocytopenia, nor the impact of platelet antibodies on the course of ITP. The gold standard analysis for the determination of platelet antibodies, is the "monoclonal antibody immobilization of platelet antigens" assay (MAIPA), either direct to detect autoantibodies attached to platelets, or indirect to detect circulating antiplatelet antibodies. Therefore, this work aims to study the contribution of the presence of anti-platelet antibodies detected in MAIPA to determine the autoimmune nature of a thrombocytopenia at diagnosis.

Participants needed: 225
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Jun 1, 2026Locations: 1
Eligibility criteria

Patient over 18 years old; [+4]

Secondary ITP; [+7]

Status: Recruiting

Ferroptosis Role in the Pathophysiology of Systemic Lupus Erythematosus

The study aims at defining the role of ferroptosis s in the physiopathology of systemic lupus erythematosus (SLE). Ferroptosis (phenomenon of cellular death regulated by iron) is a metabolic pathway potentially implicated in SLE with potential for the discovery of new therapeutic strategies.

Participants needed: 120
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: May 18, 2026Locations: 1
Eligibility criteria

age ≥ 18 years; [+3]

pregnant or breastfeeding women; [+1]

Status: Recruiting

Evaluation of the Administration of Artificial Nutrition by Feeding Jejunostomy During Neoadjuvant Treatment on Postoperative Morbidity in the Context of Esophageal or Stomach Cancer

Malnutrition is common at the time of diagnosis of esogastric cancers. However, there are no recommendations regarding preoperative nutritional support (type and duration) or on the impact of refeeding on postoperative morbidity and mortality.

Participants needed: 670
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, BordeauxUpdated: May 13, 2026Locations: 1
Eligibility criteria

Patient undergoing surgery for esophageal cancer [+2]

Patient not malnourished at the time of management [+1]

Status: Not yet recruiting

AGE Accumulation in Patients on Long-term Parenteral Nutrition

This prospective and observational study aims to evaluate the accumulation of advanced glycation end-products (AGEs) in adult and pediatric patients starting long-term parenteral nutrition, by non-invasive skin AGE measurements over a 12-month follow-up.

Participants needed: 50
Trial details
Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: May 6, 2026Locations: 3
Eligibility criteria

Patients (adults and children, all ages) initiating long-term parenteral nutriti... [+3]

Fitzpatrick skin type ≥ V (darker skin tones) [+3]

Status: Recruiting

FAPI-PET Value for the Initial Screening of Pancreatic and Biliary Cancers

Pancreatic cancer is one of the worst-prognosed cancers with a 5-year survival rate of less than 10%. Its incidence has been steadily increasing for several years in France and worldwide. Pancreatic adenocarcinoma may become the second leading cause of cancer mortality in the years 2030-2040. Current standard of care for pancreatic cancer imaging at initial workup comprise CT imaging and MRI. However, these imaging modalities lack sensitivity and accuracy, with an estimated rate of about 30% of patients either with visceral or lymph node metastasis discovered during planned surgery or with relapse occurring during the first 6 months after surgery suggesting occult metastasis at diagnosis. Therefore, there is a clear need for new imaging modalities at initial diagnosis for more adapted and individualized therapeutic decision. Cholangiocarcinoma (or cancer of the bile ducts) also has a dismal prognosis with a 5-year survival rate of 7%. The therapeutic objective is to obtain a surgical resection R0 when possible which can be associated with improved survival of up to 40% in appropriately selected patients. However, surgical morbidity and mortality are high, especially in peri-hilar forms. The detection of lymph node metastasis beyond the hepatic hilum is crucial, as surgery is considered futile in this situation. Current standard imaging at initial work-up include CT and MRI that have limited performance in estimating surgical resecability with a sensitivity of 60% for detecting lymph nodes metastasis and 67% for detecting distant metastasis. Therefore, there is also here an unmet need for improved baseline imaging. In summary, this project is focused on two digestive cancers with poor prognosis in which preoperative imaging accuracy remains today imperfect. Therefore, we aim to demonstrate, when compared with current standard imaging, that 68Ga-FAPI-46 PET/CT performed at baseline imaging in pancreatic and biliary duct cancers, leads to a change in TNM classification and subsequently to a change in therapeutic management. To our knowledge, this will be the first (or one of the first) structured multicenter prospective study to evaluate the additional and potentially decisive contribution of 68Ga-FAPI-46 PET/CT carried out after a standard imaging workup at initial diagnosis of pancreatic and biliary duct cancers. If the diagnostic superiority of 68Ga-FAPI-46 PET/CT is confirmed, this study could lead to define a new standard of care for the imaging of these cancers with poor prognosis. The study should also help to set the ground for future theranostic approaches where 68Ga-FAPI-46 PET/CT would help select patients for targeted radionuclide therapy.

Participants needed: 120
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Apr 30, 2026Locations: 1
Eligibility criteria

Population 1: De novo pancreatic adenocarcinoma (pathological evidence) or stron... [+3]

Tumor M+ or with suspicion of distant metastasis on standard staging. [+8]

Status: Not yet recruiting

Pre-anesthetic Teleconsultations During Pregnancy

Quality of teleconsultation in comparison to face-to-face consultation for pre anesthetic evaluation in pregnant persons before delivery will be evaluated. Quality is evaluated with a composite criterion comprising 7 elements required for security of anesthesia. Discordance between this composite criterion during the pre anesthesia visit the day of delivery and pre anesthesia consultation several weeks before delivery will be assessed.

Participants needed: 250
Trial details
Age: 18+Biological sex: FemaleType: InterventionalSponsor: University Hospital, BordeauxUpdated: Apr 28, 2026Locations: 1
Eligibility criteria

Pregnant patients scheduled to give birth at the Bordeaux University Hospital, A... [+2]

Minor patient (under 18 years old at the time of inclusion) [+6]

Status: Not yet recruiting

Comparing Clean Intermittent Self-catheterization and Indwelling Catheterization for the Management of Urinary Retention Before BPH Surgery.

The CATHETERS trial is a multicenter, randomized, open-label superiority study comparing two methods of managing urinary retention before surgery for benign prostatic hyperplasia (BPH): clean intermittent self-catheterization (ICSC) versus indwelling catheter (IDC). The primary objective is to determine whether ICSC reduces the occurrence of infectious complications (urinary bacterial colonization requiring antibiotic therapy, urinary tract infection, or urosepsis) compared to IDC in men awaiting BPH surgery. A total of 106 patients will be enrolled across multiple centers in France, with follow-up extending to three months after surgery.

Participants needed: 106
Trial details
Age: 50+Biological sex: MaleType: InterventionalSponsor: University Hospital, BordeauxUpdated: Apr 29, 2026Locations: 5
Eligibility criteria

Men over 50 years old; [+6]

Patient with a history of prostate surgery (including BPH surgery), prostatic ar... [+8]

Status: Recruiting

Ultradian Steroid Rhythms in Adrenal Incidentalomas

Twenty to 40% of adrenal incidentalomas are responsible for MACS (mild autonomous cortisol producing secretion). The biological tools used in current practice to explore MACS do not provide precise information on cortisol production abnormalities. This study is a comparative analysis of the dynamics/rhythmicity of interstitial cortisol and other steroid concentrations between MACS and non-secreting adenomas (ANS). Using the original and innovative U-RHYTHM system, interstitial fluid samples will be taken every 20 minutes for 24 to 48 hours from patients with MACS or non-secreting adenomas, and steroid assays will be performed in the perfusates to analyze steroid hormone production over 24 hours.

Participants needed: 40
Trial details
Age: 18+Biological sex: AllType: InterventionalSponsor: University Hospital, BordeauxUpdated: Apr 23, 2026Locations: 1
Eligibility criteria

18 < Age ≤ 85 years. [+4]

Age < 18 years [+5]

Status: Recruiting

Radiofrequency Endometrial Ablation or Uterine Artery Embolization for Treatment of Adenomyosis-related Abnormal Uterine Bleeding

The present study aims to compare the efficacy (menstrual blood loss, pain, quality of life) and the safety (complications, recovery) of each conservative intervention (RFA, UAE) versus hysterectomy for the treatment of adenomyosis-related abnormal uterine bleeding, up to 2 years

Participants needed: 230
Trial details
Age: 30-50Biological sex: FemaleType: InterventionalSponsor: University Hospital, BordeauxUpdated: Apr 20, 2026Locations: 4
Eligibility criteria

Premenopausal women aged 30 to 50 years [+8]

Uterine cavity abnormality or obstruction confirmed via imaging modalities or hy... [+16]

Status: Not yet recruiting

Pathophysiological Mechanisms Involved in the Pronostic and Evolution of Non-Small Cell Lung Cancer (NSCLC) at All Stages of the Disease

This single-center observational cohort study conducted at Bordeaux University Hospital aims to establish a structured clinico-biological platform in non-small cell lung cancer (NSCLC) to investigate the biological mechanisms involved in tumor initiation, progression, and relapse across all disease stages (I-IV). A total of 150 consecutive adult patients with histologically or cytologically confirmed NSCLC will be included over a 3-year period. Tumor samples will undergo translational analyses. These biological data will be correlated with pseudonymized clinical data collected from medical records and the institutional clinical data warehouse. The primary objective is to characterize the molecular, metabolic, and immune mechanisms associated with tumor progression and recurrence in NSCLC. The central hypothesis is that integrating comprehensive clinical data with in-depth molecular and immunological analyses of tumor tissues will identify biologically distinct patterns associated with disease evolution, therapeutic resistance, and prognosis. Such integrated clinico-biological signatures may improve patient stratification and contribute to the identification of novel biomarkers and therapeutic targets in NSCLC.

Participants needed: 150
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: University Hospital, BordeauxUpdated: Apr 17, 2026
Eligibility criteria

Adult patients [+4]

Patients with small cell lung cancer. [+7]